Anxiety-depression after intravascular ultrasound-guided drug-coated balloon angioplasty dissection: Predictors and 12-month cardiovascular outcomes

Table 3 Twelve-month clinical outcomes, n (%)

Endpoint	Anxiety-depression cohort (n = 65)	Stable cohort (n = 103)	P value
Composite MACE	18 (27.7)	9 (8.7)	0.002
Cardiac death	3 (4.6)	2 (1.9)	0.247
Non-fatal MI	5 (7.7)	2 (1.9)	0.048
Target lesion revascularization	10 (15.4)	5 (4.9)	0.018
Target vessel revascularization	12 (18.5)	7 (6.8)	0.022
Unplanned CV rehospitalization	13 (20.0)	8 (7.8)	0.016
All-cause mortality	4 (6.2)	3 (2.9)	0.272
Stroke/TIA	2 (3.1)	1 (1.0)	0.340
New-onset heart failure	5 (7.7)	3 (2.9)	0.141
Recurrent angina (CCS ≥ II)	18 (27.7)	12 (11.7)	0.006

MACE: Major adverse cardiovascular events; MI: Myocardial infarction; CV: Cardiovascular; TIA: Transient ischemic attack; CCS: Canadian Cardiovascular Society.